Juul is thinking about opening retail stores. The company said it hasn’t made a final decision about brick-and-mortar locations, but has hired staff for potential shops in Dallas and Houston that would only admit adults. The stores could also help Juul gain sales insights that it could use elsewhere. (Wall Street Journal)

Meanwhile, Sen. Richard Durbin (D-IL) said acting FDA Commissioner Ned Sharpless isn’t being aggressive enough in trying to curb teen vaping. Durbin called a recent meeting with Sharpless “one of the most disappointing and alarming” of his Senate career. (CNBC)

The number of measles cases reported in 2019 has surpassed 1994’s mark of 963, according to the Centers for Disease Control and Prevention. In the first five months of this year, 971 cases have been reported in 26 states. (ABC News)

The cost of healthcare is the top financial issue among American families, according to a Gallup poll released this week. Seventeen percent of respondents said healthcare costs are their top financial issue, followed by lack of money or low wages (11%), college expenses (8%), the cost of owning or renting a home (8%) and paying taxes (8%). (The Hill)

Novo Nordisk’s investment arm is putting more than $67 million into Oxford Biomedica, a U.K.-based gene and cell therapy group. Oxford will use the investment to repay debt and develop its LentiVector platform. (Endpoints)